This CPD accredited meeting is designed to discuss the advances made in ELISPOT technology including the range of cytokines that can be measured, as well discussions on assay development and applications to both basic and clinical research. The agenda features an international line-up of experts in the field. The deadline for early registration is April 20th 2008.

 

"ELISPOT technology will cover all aspects of the assay development from initial cell stimulation to analyzing spot formation". Chair – Dr Sefina Arif (Kings College, London).

 

Speakers include:


Professor Paul Lehmann, Professor of Pathology at Case Western Reserve University, USA

 

Professor Ajit Lalvani, Head, Tuberculosis Immunology Group, National Heart and Lung Institute, UK

 

Dr Roberto Mallone, Hopital Saint Vincent de Paul, France


Dr Peter Vander Meide, U-CyTech biosciences, The Netherlands


Dr Werner Freber, CEO and founder of BIO-SYS GmbH, Germany

 

Dr Huriya Beyan, Queen Mary, University of London, UK


Assoc. Professor Niklas Ahlborg, Mabtech AB, Sweden

 

To see the agenda and/or book, please visit www.regonline.com/elispot08 .

 

There is still time to submit an abstract - those accepted for poster and oral presentations will also be published in the proceedings. There will be a prize for the best poster. Abstract guidelines can be found at http://www.euroscicon.com/absguidlines.html